Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

MDxHealth SA Ordinary Shares (MDXH)

https://www.mdxhealth.com

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/14/2008

Market Cap

87,321,920

Shares Outstanding

27,290,000

Weighted SO

27,288,093

Total Employees

N/A

Upcoming Earnings

08/07/2024

Similar Tickers

INZY --.--%

DAWN --.--%

ABOS --.--%

ELDN --.--%

ELEV --.--%

Beta

-392096.9700

Last Div

0.0000

Range

0.35-4.64

Chg

0.3900

Avg Vol

25856

Mkt Cap

87321920

Exch

NASDAQ

Country

BE

Phone

32 4 257 70 21

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

1.1592

EV Multiple

-5.2198

P/FV

-89.7450

Div Yield %

0.0000

P/E

-2.1884

PEG

-0.0461

Payout

0.0000

Current Ratio

1.6879

Quick Ratio

1.5273

Cash Ratio

0.7649

DSO

61.3881

DIO

36.6662

Op Cycle

98.0544

DPO

105.5057

CCC

-7.4514

Gross Margin

0.5977

Op Margin

-0.3374

Pretax Margin

-0.5297

Net Margin

-0.5297

Eff Tax Rate

-0.0172

ROA

-0.3278

ROE

-3.1458

ROCE

-0.2472

NI/EBT

1.0000

EBT/EBIT

1.5699

EBIT/Rev

-0.3374

Debt Ratio

0.3120

D/E

-39.0380

LT Debt/Cap

1.0280

Total Debt/Cap

1.0263

Int Coverage

-17.9112

CF/Debt

-0.6298

Equity Multi

-125.1233

Rec Turnover

5.9458

Pay Turnover

3.4595

Inv Turnover

9.9547

FA Turnover

8.0280

Asset Turnover

0.6187

OCF/Share

-0.8767

FCF/Share

-1.0411

Cash/Share

0.5311

OCF/Sales

-0.3176

FCF/OCF

1.1876

CF Coverage

-0.6298

ST Coverage

-10.8296

CapEx Coverage

-5.3309

Div&CapEx Cov

-5.3309

P/BV

-89.7450

P/B

-89.7450

P/S

1.1592

P/E

-2.1884

P/FCF

-3.0736

P/OCF

-3.6502

P/CF

-3.6502

PEG

-0.0461

P/S

1.1592

EV Multiple

-5.2198

P/FV

-89.7450

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Sep 13, 00:30 Liquid Biopsy Market to Reach $ 32.54 Billion, Globally, by 2033 at 11.61% CAGR: The Brainy Insights Benzinga Jan 09, 02:03 TD SYNNEX, Albertsons And 3 Stocks To Watch Heading Into Tuesday GlobeNewswire Inc. Dec 18, 01:00 MDxHealth Announces Completion of Transition to Single Listing on Nasdaq GlobeNewswire Inc. Dec 18, 01:00 MDxHealth annonce la réalisation de sa transition vers une cotation unique sur le Nasdaq GlobeNewswire Inc. Dec 18, 01:00 MDxHealth Announces Completion of Transition to Single Listing on Nasdaq GlobeNewswire Inc. Dec 18, 01:00 MDxHealth annonce la réalisation de sa transition vers une cotation unique sur le Nasdaq GlobeNewswire Inc. Dec 18, 01:00 MDxHealth Announces Completion of Transition to Single Listing on Nasdaq GlobeNewswire Inc. Dec 18, 01:00 MDxHealth annonce la réalisation de sa transition vers une cotation unique sur le Nasdaq GlobeNewswire Inc. Nov 27, 01:00 MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq GlobeNewswire Inc. Nov 27, 01:00 MDxHealth annonce la réalisation de l'échange obligatoire d'ADS et le début de la période de transition vers une cotation unique sur le Nasdaq GlobeNewswire Inc. Nov 27, 01:00 MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq GlobeNewswire Inc. Nov 27, 01:00 MDxHealth annonce la réalisation de l'échange obligatoire d'ADS et le début de la période de transition vers une cotation unique sur le Nasdaq GlobeNewswire Inc. Nov 27, 01:00 MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq GlobeNewswire Inc. Nov 27, 01:00 MDxHealth annonce la réalisation de l'échange obligatoire d'ADS et le début de la période de transition vers une cotation unique sur le Nasdaq GlobeNewswire Inc. Nov 27, 01:00 MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq GlobeNewswire Inc. Nov 06, 01:00 MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation GlobeNewswire Inc. Nov 06, 01:00 MDxHealth annonce l'approbation par ses actionnaires de la proposition de transition vers une cotation unique des actions sur le Nasdaq, ainsi que les détails du regroupement d'actions GlobeNewswire Inc. Nov 06, 01:00 MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation GlobeNewswire Inc. Nov 06, 01:00 MDxHealth annonce l'approbation par ses actionnaires de la proposition de transition vers une cotation unique des actions sur le Nasdaq, ainsi que les détails du regroupement d'actions GlobeNewswire Inc. Nov 06, 01:00 MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation

Revenue Product Segmentation